Inogen Inc (INGN)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $147.95M
Last updated: Nov 17, 2026 at 4:10 PM ET
Inogen Inc (INGN) Statistics
Inogen (INGN) has a market cap of $147.95M and an enterprise value of $66.11M. It holds $81.84M more cash than debt, 55.32% of its market cap. Its share count is down 2.27% from a year earlier.
Total Valuation
Enterprise value is 55.32% below the market cap, as cash exceeds debt.
| Market Cap | $147.95M |
|---|---|
| Enterprise Value | $66.11M |
| Latest price (Nov 17, 2026) | $5.68 |
Key Dates
| Last Earnings Date | Nov 5, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.4x and 1.0x. Its year-end P/S ranged from 0.4x to 10.0x from 2016 to 2025.
| P/S Ratio | 0.4x |
|---|---|
| Forward P/S | 0.5x |
| P/B Ratio | 1.0x |
| P/TBV Ratio | 1.1x |
Price Statistics
The stock is down 17.61% over 52 weeks and trades 5.49% below its 50-day average.
| Beta (1Y) | 0.59 |
|---|---|
| 52-Week Change | -17.61% |
| 1-Month Change | -13.21% |
| 3-Month Change | +0.09% |
| 6-Month Change | -11.86% |
| 5-Year Change | -82.70% |
| 10-Year Change | -87.22% |
| Total Return (1Y) | -17.61% |
| Total Return (3Y CAGR) | -0.32% |
| Total Return (5Y CAGR) | -30.09% |
| Return vs SPY (1Y) | -28.57% |
| Max Drawdown (1Y) | -30.75% |
| Max Drawdown (3Y) | -60.79% |
| Sharpe Ratio (1Y) | -0.41 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $6.01 |
| 200-Day Average | $6.23 |
| 52-Week Range | $5.04 to $7.67 |
| RSI (14 Days) | 37.2 |
| Average Volume (20 Days) | 298.27K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.96x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 2.96x |
|---|---|
| Quick Ratio | 2.55x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -22.59% over the last 12 months, against a 5-year average of -22.47%.
| Return on Equity (ROE) | -22.59% |
|---|---|
| Return on Assets (ROA) | -13.38% |
| ROE (5Y Average) | -22.47% |
| ROA (5Y Average) | -14.62% |
| ROIC (5Y Average) | -14.05% |
| Asset Turnover | 1.19x |
| Inventory Turnover | 6.55x |
| Receivables Turnover | 7.16x |
| Cash Conversion Cycle | 29 days |
Scores
INGN has an Altman Z-Score of 1.19, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.19 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $339.11M over the last 12 months is up 1.61% from the 12 months before.
| Revenue | $339.11M |
|---|---|
| Revenue Growth (YoY) | +1.61% |
| Gross Profit | $150.38M |
| Operating Income | -$39.32M |
| Pretax Income | -$34.51M |
| Net Income | -$35.46M |
| EBITDA | -$26.61M |
| Reported EPS (TTM) | -$0.99 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 59.26% of the $264.91M in total assets.
| Cash and Equivalents | $81.84M |
|---|---|
| Total Debt | $0 |
| Net Cash | $81.84M |
| Net Cash Per Share | $3.09 |
| Working Capital | $138.06M |
| Shareholder Equity | $156.99M |
| Book Value Per Share | $5.93 |
| Tangible Book Value | $130.91M |
| Tangible Book Per Share | $4.95 |
| Total Assets | $264.91M |
| Total Liabilities | $107.92M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $2.18M of capital spending, operating cash flow left -$11.33M of free cash flow.
| Operating Cash Flow | -$9.15M |
|---|---|
| Capital Expenditures | $2.18M |
| Free Cash Flow | -$11.33M |
| FCF Per Share | -$0.43 |
| Depreciation and Amortization | $17.63M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -11.60%, against a 5-year average of -15.20%.
| Gross Margin | 44.35% |
|---|---|
| Operating Margin | -11.60% |
| Pretax Margin | -10.18% |
| Net Margin | -10.46% |
| EBITDA Margin | -7.85% |
| FCF Margin | -3.34% |
| Gross Margin (5Y Average) | 44.09% |
| Operating Margin (5Y Average) | -15.20% |
| Net Margin (5Y Average) | -14.73% |
Growth
Revenue fell 2.59% a year over 3 years.
| Revenue Growth (3Y CAGR) | -2.59% |
|---|---|
| Revenue Growth (5Y CAGR) | +2.48% |
| Book Value Per Share Growth (2Y CAGR) | -10.27% |
| Tangible Book Per Share Growth (2Y CAGR) | -10.14% |
Dividends and Yields
INGN does not pay a dividend. Its free cash flow yield is -7.53%.
| FCF Yield | -7.53% |
|---|---|
| Buyback Yield | 6.99% |
| Shareholder Yield | 6.99% |
Peer Position
Against 12 similar companies, INGN has the 12th highest P/S.
P/S RatioPeer median 2.3x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.76%
| P/S Ratio | 0.4x vs 2.3x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +1.61% vs +13.76% median |
Analyst Forecast
Consensus estimates put revenue growth at -6.02% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -6.02% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INGN
What is INGN's market cap?
Inogen has a market cap of $147.95M. Its enterprise value, which adds debt and subtracts cash, is $66.11M.
How many shares of INGN are outstanding?
Inogen has 26.46M shares outstanding. The count is down 2.27% from a year earlier.
Does INGN pay a dividend?
No. Inogen does not pay a dividend.
How much debt does INGN have?
Inogen has $0 of total debt and $81.84M of cash and equivalents, a net cash position of $81.84M.
INGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts